13F-HR filed by GREAT POINT PARTNERS LLC
GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 35 holding rows worth $641,637,881.
- Accession
- 0001172661-24-002523
- Filer
- CIK 1281446
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 35 entries on the cover page, a total value of $641,637,881 stated on the cover page (in dollars after the unit check, H1), rows summing to $641,637,881 with VALUE read as dollars as filed, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJAY JEFFREY R028-12517
- included managerYehudai Ortav028-20398
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NEUROGENE INC | 64135M105 | COMMON STOCK | 1,004,291 | $51,118,412 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 1,128,499 | $44,733,700 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 2,620,545 | $39,308,175 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 2,488,483 | $35,585,307 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 2,450,000 | $34,300,000 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 1,851,864 | $27,592,774 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 400,000 | $26,580,000 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 887,690 | $26,248,993 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,335,000 | $23,375,850 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 976,981 | $22,001,612 | dollars as filed | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 8,000,000 | $21,440,000 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 775,585 | $21,041,621 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 300,000 | $20,865,000 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 456,148 | $19,637,171 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 2,000,000 | $18,800,000 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 625,000 | $18,750,000 | dollars as filed | |
| OUTLOOK THERAPEUTICS INC | 69012T305 | COM | 1,480,000 | $17,671,200 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 1,495,500 | $17,616,990 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 1,728,723 | $15,731,379 | dollars as filed | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 1,264,920 | $15,697,657 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 202,202 | $14,176,382 | dollars as filed | |
| OPTINOSE INC | 68404V100 | COM | 8,786,318 | $12,828,024 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 407,550 | $11,965,668 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 150,000 | $10,380,000 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 223,288 | $10,054,659 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 1,858,735 | $9,814,121 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 1,309,975 | $8,593,436 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 115,000 | $7,475,000 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 1,166,667 | $7,443,335 | dollars as filed | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 1,343,628 | $7,121,228 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 2,757,740 | $7,087,392 | dollars as filed | |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 500,000 | $5,200,000 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 125,000 | $4,741,250 | dollars as filed | |
| KYVERNA THERAPEUTICS INC | 501976104 | COMMON STOCK | 150,000 | $3,726,000 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 71,113 | $2,935,545 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-24-002523 | this filing | 2024-05-15 | acceptance time not in the bulk data set |